glp-1 faa medical medications safe to continue before surgery in patients with diabetes and obesity GLP-1 Safety Check - National

Compounded drugs do not undergo the same amount of testing for safety, effectiveness, and quality that FDA-approved drugs do, so they naturally pose a higher risk to people taking them

Many patients taking Victoza report gastrointestinal side effects, and some claims allege that serious complications may develop after prolonged use

GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD

As such, -cells are staunchly resilient but there are circumstances where they can become functionally compromised or physically lost due to pathophysiological changes which culminate in overt hyperglycemia and diabetes

Diab Investig

How Weight Loss Injections Interact with HRT: The 2026 Clinical View Understanding the physiological intersection between GLP-1 receptor agonists and hormone replacement therapy is essential for patient safety